510(k) Report

510(k) · Cleared

Cleared

Smart HBA1C Assay Kit, Model DZ168B-Poc, Smart HBA1C Assay Control Kit, Model DZ168B-Con, Smart HBAC1C Analyzer

K092911510(k) TraditionalCleared Apr 26, 2010216-day reviewClass I21 CFR 862.1660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diazyme Laboratories · JJX Single (Specified) Analyte Controls (Assayed And Unassayed)

Cleared on Apr 26, 2010 as substantially equivalent to K070734 (Diazyme Laboratories, 2007) after a 216-day review. Its family tree reaches back 1 generation to 2007. 1 later device descends from it.

Decided
Apr 26, 2010
Review
216 days
Class
Class I
Product code
JJX
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K070734 (2007). 1 later device descends from it, 1 citing it directly.

Descendants, by generation 1 generation forward: 1 descendant K070734 · Modification to: Direct Enzymatic HBA1C Assay Kit, Model# DZ168A, DZ168A-Cal, DZ168A-Con · Diazyme Laboratories · 2007 · recalled0
  1. Root · 1 generation backK070734 Modification to: Direct Enzymatic HBA1C Assay Kit, Model# DZ168A…Diazyme Laboratories · 2007 · Recalled
  2. This deviceK092911 Smart HBA1C Assay Kit, Model DZ168B-Poc, Smart HBA1C Assay Control…Diazyme Laboratories · 2010
  3. Descendant · cites it directly · 0 of its ownK111664 Diazyme Cystatin C Poc Test KitDiazyme Laboratories · 2012

Most influential descendants

Showing 1 of 1 · See all
  • K111664Diazyme Cystatin C Poc Test KitDiazyme Laboratories · 2012 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K070734Modification to: Direct Enzymatic HBA1C Assay Kit, Model# DZ168A, DZ168A-Cal…Diazyme Laboratories20071
0 (this device)K092911Smart HBA1C Assay Kit, Model DZ168B-Poc, Smart HBA1C Assay Control Kit, Model…Diazyme Laboratories2010—
+1K111664Diazyme Cystatin C Poc Test KitDiazyme Laboratories2012—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
FIG. 1 — Lineage of K092911, 2007–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JJX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070734Modification to: Direct Enzymatic HBA1C Assay Kit, Model# DZ168A, DZ168A-Cal, DZ168A-Con
Summary page 2
…ubstantially equivalent to the currently marketed Diazyme Direct Enzymatic HbAlc Assay (k070734). Manufacturing Address Diazyme Laboratories 12889 Gregg Court…
Diazyme Laboratories20071
†K050178HBA1C Enzymatic AssayGeneral Atomics2005—

Also cleared against K070734: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K111664Diazyme Cystatin C Poc Test KitDiazyme Laboratories20120

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K111664 (Diazyme Laboratories, 2012) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K070734.

How does its category compare?

All JJX devices

JJX Single (Specified) Analyte Controls (Assayed And Unassayed): FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · JJX

2in 2017

2007: 62008: 82009: 172010: 242011: 192012: 152013: 192014: 222015: 112016: 62017: 2
2007high 24 (2010) · low 0 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JJX

31in 2016

2007: 53 days median2008: 52 days median2009: 80 days median2010: 80 days median2011: 62 days median2012: 40 days median2013: 37 days median2014: 30 days median2015: 65 days median2016: 31 days median
2007high 80 (2009) · low 30 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JJX

1in 2021

2007: 32008: 32010: 32011: 22014: 12015: 12016: 22018: 22021: 1
2007high 3 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JJX

22in 2025

2007: 22009: 12010: 62011: 622012: 322013: 512014: 482015: 672016: 372017: 192018: 352019: 822020: 772021: 432022: 242023: 222024: 302025: 22
2007high 82 (2019) · low 0 (2008)2025

MAUDE reports naming product code JJX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200765332
200885230
2009178001
2010248036
20111962262
20121540032
20131937051
20142230148
20151165167
2016631237
20172—019
20180—235
20190—082
20200—077
20210—143
20220—024
20230—022
20240—030
20250—022
20260—0—

What is it indicated for?

SMART Hemoglobin Alc (Glycated hemoglobin Alc; Alc; HbAlc) Assay Reagent Kit is intended for use with the SMART analyzer for the quantitative determination of stable H-bAic in human capillary and venous whole blood samples. Measurement of hemoglobin Alc is a valuable indicator for long-term diabetic control. For in vitro diagnostic use only. SMART HbAlIc Assay Controls are intended for use as quality controls for the SMART HbAlIc Assay reagents. For in…

Read the full statement (122 words)

SMART Hemoglobin Alc (Glycated hemoglobin Alc; Alc; HbAlc) Assay Reagent Kit is intended for use with the SMART analyzer for the quantitative determination of stable H-bAic in human capillary and venous whole blood samples. Measurement of hemoglobin Alc is a valuable indicator for long-term diabetic control. For in vitro diagnostic use only.

SMART HbAlIc Assay Controls are intended for use as quality controls for the SMART HbAlIc Assay reagents. For in vitro diagnostic use only.

SMART analyzer is a compact cuvette based spectrophotometei machine for point-of-care use, designed to analyze readings from single use SMART reagent cuvette. The SMART Analyzer System, consisting of the SMART Analyzer, SMART HbAlc reagent kit and SMART HbAlc Assay Controls, is for in vitro diagnostic use only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K092911: Smart HBA1C Assay Kit, Model DZ168B-Poc, Smart HBA1C Assay Control Kit, Model DZ168B-Con, Smart HBAC1C Analyzer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K092911

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026